Published 5 days ago • loading... • Updated 5 days ago

Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies

Kelun-Biotech announced on Jan. 6, 2026, it will present at the 44th J.P. Morgan Healthcare Conference during January 2026. Dr. Michael Ge will speak.
Sichuan Kelun-Biotech Co., Ltd. focuses on solid tumors, autoimmune, and metabolic diseases, and aims 'to become a leading global enterprise in innovative drugs,' according to the company.
The company highlights its OptiDC proprietary ADC and novel DC platforms and more than 30 ongoing key innovative drug projects including 2 ADC projects approved for marketing.
Kelun-Biotech will use the forum to join seasoned experts and industry leaders at JPMHC to share its progress and innovation strategies, seeking mutually beneficial international partnerships amid industry transformation.
Held at Westin St. Francis, San Francisco, the 44th J.P. Morgan Annual Healthcare Conference is a benchmark for development and investment in the global healthcare area.

Insights by Ground AI

54 Articles

Bennington Banner

+53 Reposted by 53 other sources

Center

Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies

CHENGDU, China, Jan. 6, 2026 /PRNewswire/ -- The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) has been…

5 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year